. Author manuscript; available in PMC: 2014 May 1.

Published in final edited form as: J Subst Abuse Treat. 2012 Dec 3;44(5):473–480. doi: 10.1016/j.jsat.2012.10.004

Table 3.

Medication assisted treatment (MAT) among drug courts in 2010 (N=93)

	N (%)^*
Any MAT (for opioid dependence)	60 (56)
Agonist MAT	45 (47)
Methadone maintenance	26 (26)
Buprenorphine maintenance	37 (40)
Any Naltrexone	17 (18)
Naltrexone as a pill	12 (13)
Naltrexone as a monthly injection (Vivitrol)	7 (8)
Counseling	87 (92)
Opioid detox services (with or without use of medications)	51 (56)

all percentages weighted to account for over/underrepresentation of courts in rural, suburban, and urban regions.